GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 57 filers reported holding GT BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,962 | -22.7% | 95,239 | 0.0% | 0.00% | – |
| Q2 2023 | $29,714 | -43.3% | 95,239 | 0.0% | 0.00% | – |
| Q1 2023 | $52,382 | -37.9% | 95,239 | 0.0% | 0.00% | – |
| Q4 2022 | $84,353 | -49.5% | 95,239 | 0.0% | 0.00% | – |
| Q3 2022 | $167,000 | -43.2% | 95,239 | -3.5% | 0.00% | – |
| Q2 2022 | $294,000 | -28.1% | 98,664 | -30.5% | 0.00% | – |
| Q1 2022 | $409,000 | -7.3% | 142,048 | -2.1% | 0.00% | – |
| Q4 2021 | $441,000 | -52.3% | 145,123 | +5.8% | 0.00% | – |
| Q3 2021 | $925,000 | +1.6% | 137,156 | +133.6% | 0.00% | – |
| Q2 2021 | $910,000 | – | 58,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |